NRP1 and acute lymphoblastic leukemia: The aim of the study was to determine the fluctuation of four markers expression: CD66c, CD304, CD86 and CD72 on leukemic blasts in pediatric patients with BCP-ALL, by comparing the expression levels of above mentioned antigens at day 15 and 33 of induction treatment and the diagnosis (day 0).